REQUEST A DEMO
Total
USD $0.00
Search more companies

Balkanpharma Troyan AD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Balkanpharma Troyan AD Profile Updated: September 08, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Balkanpharma Troyan, which was established in 1953, is the one of the largest producers of pharmaceuticals in Bulgaria. The company is a successor of state-owned Troyanpharm. It sells more than 90% of its production abroad. Balkanpharma Troyan has a product portfolio of over 100 pharmaceuticals including tablets, syrups, capsules, infusion solutions, creams, ointments, gel forms, anti-acid suspensions, granules and aerosols.
In June 1999, local company Balkanpharma became Bulgaria's largest pharmaceuticals group after acquiring three drug makers – Troyanpharm, which produces liquid drugs only, an antibiotics maker in Razgrad and a plant in Dupnitsa, which focuses on solid dose drugs. The total sum of the deal was USD 24 million. In December 2000, Iceland-based generic drugs maker Pharmaco (later renamed Actavis) acquired Balkanpharma Holding, gaining control of its three plants. Currently, Balkanpharma Troyan is part of Actavis Group and is operated and owned by Actavis Operations EOOD.

Headquarters
1 Krayrechna Str.
Troyan; Lovech; Postal Code: 5600

Contact Details: Purchase the Balkanpharma Troyan AD report to view the information.

Website: http://www.actavis.bg

Basic Information
Total Employees:
Purchase the Balkanpharma Troyan AD report to view the information.
Outstanding Shares:
Purchase the Balkanpharma Troyan AD report to view the information.
Registered Capital:
Purchase the Balkanpharma Troyan AD report to view the information.
Financial Auditors:
Purchase the Balkanpharma Troyan AD report to view the information.
Incorporation Date:
August 15, 1991
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
98.32%
Purchase this report to view the information.
0.02%
Purchase this report to view the information.
0.02%
Company Performance
Financial values in the chart are available after Balkanpharma Troyan AD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
0%
Total operating revenue
0.02%
Operating profit (EBIT)
-15.48%
EBITDA
-10.55%
Net Profit (Loss) for the Period
-21.05%
Total assets
-0.83%
Total equity
3.94%
Operating Profit Margin (ROS)
-1.13%
Net Profit Margin
-1.62%
Return on Equity (ROE)
-1.2%
Quick Ratio
0.66%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?